Aclaris Therapeutics, Inc.
News
Aclaris Therapeutics to Participate in the 2024 Cantor Global Healthcare Conference
Globe Newswire WAYNE, Pa., Sept. 10, 2024 (GLOBE NEWSWIRE) -- Aclaris Therapeutics, Inc. (NASDAQ: ACRS), a clinical-stage biopharmaceutical company focused on developing novel drug candidates for...\n more…
Aclaris Therapeutics (NASDAQ:ACRS) Shares Pass Below 50 Day Moving Average of $1.24
Ticker Report Aclaris Therapeutics, Inc. (NASDAQ:ACRS - Get Free Report)'s stock price passed below its fifty day moving average during trading on Thursday . The stock has a fifty day moving average of $1.24 and...\n more…
Aclaris Therapeutics (NASDAQ:ACRS) Shares Cross Below 50 Day Moving Average of $1.24
Ticker Report Aclaris Therapeutics, Inc. (NASDAQ:ACRS - Get Free Report) shares crossed below its 50-day moving average during trading on Wednesday . The stock has a 50-day moving average of $1.24 and traded as...\n more…
Aclaris Therapeutics, Inc. to Post FY2024 Earnings of ($0.66) Per Share, HC Wainwright Forecasts (NASDAQ:ACRS)
Ticker Report Aclaris Therapeutics, Inc. (NASDAQ:ACRS - Free Report) - Equities research analysts at HC Wainwright increased their FY2024 earnings per share (EPS) estimates for shares of Aclaris Therapeutics in a...\n more…
H.C. Wainwright Reaffirms Their Hold Rating on Aclaris Therapeutics (ACRS)
TipRanks Financial Blog In a report released today, Ram Selvaraju from H.C. Wainwright reiterated a Hold rating on Aclaris Therapeutics (ACRS - Research Report). The compa...\n more…
Aclaris Therapeutics, Inc. (NASDAQ:ACRS) Short Interest Update
Ticker Report Aclaris Therapeutics, Inc. (NASDAQ:ACRS - Get Free Report) saw a large decrease in short interest in July. As of July 31st, there was short interest totalling 1,860,000 shares, a decrease of 13.9...\n more…